# Pure Bioscience, Inc. > Clarifo company profile — qualitative business description generated from > the company's filings. Financial statements, charts and ratios are > available on Clarifo (https://www.clarifo.com/en/companies/Pure Bioscience, Inc.). ## Overview PURE Bioscience, Inc. develops and commercializes antimicrobial products based on patented stabilized ionic silver technology. Its core offerings use Silver Dihydrogen Citrate (SDC) in liquid formulations for sanitation, disinfection, and food-safety applications, and the company also supplies SDC-based ingredients for personal care uses. ## Products & services • SDC-based antimicrobial disinfectants and sanitizers • PURE® Hard Surface food-contact sanitizer/disinfectant • PURE Control® direct food-contact processing aid • SDC raw material ingredients for personal care products • Contract manufacturing of SDC-based formulations - **Food safety sanitizers and disinfectants** (60%) — EPA/FDA/Health Canada-registered SDC products used on food-contact surfaces and in processing environments. - **Direct food-contact processing aids** (20%) — SDC formulations used in food processing applications where direct contact is permitted. - **Raw material ingredients** (10%) — SDC supplied as an ingredient for third-party personal care and related formulations. - **Contract manufacturing** (10%) — Manufacture and sale of SDC-based products for end use or as manufacturing inputs. - SDC-based antimicrobial disinfectants and sanitizers - PURE® Hard Surface food-contact sanitizer/disinfectant - PURE Control® direct food-contact processing aid - SDC raw material ingredients for personal care products - Contract manufacturing of SDC-based formulations ## Customers PURE sells to food-industry end users that need antimicrobial control across production, handling, and transport. Its products are also sold through distributors, which broadens access to smaller accounts and regional markets. The customer base includes restaurant chains, food processors, food manufacturers, and transportation companies, plus third parties that buy SDC as an ingredient or formulation input. - **Restaurant chains** (primary) — Buy food-contact surface sanitizer/disinfectant for hygiene and compliance. - **Food processors** (primary) — Use PURE Control and related SDC products in processing environments. - **Food manufacturers** (secondary) — Purchase antimicrobial products to support sanitation and food safety. - **Food transportation companies** (secondary) — Use sanitizing products for surfaces and handling equipment in transit. - **Distributors** (primary) — Buy and resell SDC products to extend market reach and local coverage. - **Personal care formulators** (emerging) — Source SDC as a raw ingredient for third-party product formulations. - Restaurant chains buying food-contact sanitizers for hygiene control - Food processors using SDC in processing and sanitation steps - Food manufacturers seeking antimicrobial solutions for production lines - Transportation companies needing surface sanitation products - Distributors that resell into local food-safety channels ## Geography PURE is a U.S.-based company and its registered products are cleared for use in the United States, with additional registration in Canada. The business is built around domestic commercialization and distributor-led reach, while also pursuing third-party approvals for markets outside the U.S. Geography matters because regulatory approvals, local distributor coverage, and food-safety standards shape where the products can be sold. - United States is the core operating and sales market - Canada is an approved market through Health Canada registration - Distribution partners help extend reach across U.S. regions - International expansion depends on third-party approvals - Regulatory status by country affects where products can be sold ## Strategy PURE’s strategy centers on commercializing its SDC platform in food safety, expanding through distributors, and adding new products and applications. It also seeks third-party partnerships for approvals outside the U.S. and aims to protect its intellectual property while broadening the technology platform into additional revenue streams. - **Grow the distribution network** (short-term) — Distributors extend reach, reduce logistics burden, and speed market access. - **Pursue approvals and partnerships outside the U.S.** (medium-term) — International approvals can open new markets without building a full direct-sales footprint. - **Develop new proprietary products and applications** (medium-term) — New formulations can broaden the platform beyond current food-safety uses. - **Protect intellectual property** (long-term) — Patent protection supports differentiation and helps defend the SDC platform. - Expand distributor network to widen market access - Use third-party partners for non-U.S. approvals and market entry - Develop additional proprietary products and applications - Protect and enhance intellectual property around SDC - Build multiple revenue streams from licensing and collaborations ## Risks PURE faces commercialization risk because its products must gain broader acceptance in a competitive food-safety market where customers are price-sensitive and incumbents are larger and better resourced. The company also depends on regulatory approvals, distributor execution, and external financing, so delays in sales adoption or capital access could materially affect operations. - **Limited market acceptance of SDC products** [high] — Customers may not adopt the products broadly despite efficacy benefits. - **Intense competition from larger food-safety companies** [high] — Rivals have broader product lines, stronger brands, and more resources. - **Regulatory approval delays** [medium] — Sales depend on EPA, FDA, Health Canada, and other approvals. - **Financing and going-concern risk** [critical] — Operations depend on external capital until operating cash generation improves. - **Intellectual property protection risk** [medium] — The platform depends on patents and proprietary formulations for differentiation. - Broad market acceptance of SDC products is not assured - Competitors may offer cheaper or better-established alternatives - Regulatory approvals can delay product launches and expansion - Distributor performance affects sales reach and execution - External financing is needed to fund operations and growth ## Accounting Revenue is recognized under ASC 606 when control of goods or services transfers, which makes shipment timing and contract terms important for quarter-to-quarter results. The company also records deferred revenue for amounts received in advance, and its manufacturing, inventory, and product-registration costs can affect reported margins and expense timing. Because the business is still commercializing, estimates around collectability, inventory reserves, and going-concern assumptions are especially important for investors. - **Revenue recognition timing** — Quarterly revenue comparability - **Deferred revenue** — Balance sheet liabilities and future revenue conversion - **Inventory and manufacturing cost allocation** — Gross margin and inventory valuation - **R&D and product registration costs** — Operating expense volatility - **Going-concern assessment** — Financial statement presentation and risk disclosure - Revenue recognition depends on transfer of control under ASC 606 - Advance payments are recorded as deferred revenue until earned - Manufacturing costs flow through inventory and cost of goods sold - R&D includes product registration and third-party testing costs - Going-concern assumptions affect asset and liability presentation --- *Last updated: 2026-04-29T04:47:21.479789+00:00*